Bill C-30 was passed by the Senate on May 11 2017 (for more information see "Bill C-30 ushers in changes to Canadian pharma patent regulations"). Bill C-30 implements the Canada-EU Comprehensive Economic and Trade Agreement. On May 16 2017 the bill received royal assent and became an act. However, apart from certain coordinating amendments, the act will not come into force until there is an order in council. Further, before many provisions come into force, regulations will need to be registered.
For further information on this topic please contact Daphne Lainson at Smart & Biggar/Fetherstonhaugh's Ottawa office by telephone (+1 613 232 2486) or email ([email protected]). Alternatively, contact Nancy Pei at Smart & Biggar/Fetherstonhaugh's Toronto office by telephone (+1 416 593 5514) or email ([email protected]ar.ca). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.